Qilu Pharmaceutical's Novel Anti-Tumor Drug QLS5132 Granted IND Approval for Advanced Solid Tumors

May 06, 2025 19:34 CST Updated 19:34

Qilu Pharmaceutical

Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer

Recently, according toThe official website of the National Medical Products Administration (CDE) announced that "QLS5132 for Injection" from Qilu Pharmaceutical Co., Ltd. has received tacit approval for clinical trials.For patients with advanced solid tumors.

Patients with advanced solid tumors often face limited treatment options and poor prognosis. Currently, many patients with advanced solid tumorsPatients may still experience recurrence or drug resistance after undergoing traditional surgery, radiotherapy, chemotherapy, as well as existing targeted therapy and immunotherapy, facing the dilemma of having no standard treatment options available.

Relevant studies show that patients with advanced solid tumors often experience severe side effects when receiving existing therapies, impacting their quality of life.Therefore, the development of new drugs that can effectively reduce side effects has become an urgent need in the medical field.

It is reported that, in the field of anti-tumor chemical drugs

，

In the TOP5 brands of anti-tumor chemical drugs in the first half of 2024, AstraZeneca's Osimertinib Mesylate Tablets, China Resources Tianqing Pharmaceutical Group's Anlotinib Hydrochloride Capsules, and Jiangsu Hansoh Pharmaceutical Group's Almonertinib Mesylate Tablets ranked in the top three, respectively. Among them, Jiangsu Hansoh Pharmaceutical Group's Almonertinib Mesylate Tablets increased by approximately 47%. Except for CSPC Ouyi Pharmaceutical's Doxorubicin Hydrochloride Liposome Injection, all others are innovative drugs and belong to protein kinase inhibitors.

Operation｜Twenty-thirteen

Hengrui and Zhixiang Jintai Plan to Go All-In

President of a tertiary hospital attacked; celebrity chairman steps down; two pharmaceutical companies heavily fined for monopoly

14,000 Stores Closed in Three Months, End of a Crazy Era